Krystal Biotech, Inc.
KRYS
$180.30
-$3.62-1.97%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 597.52M | 588.32M | 559.61M | 538.26M | 532.18M |
| Total Receivables | 104.75M | 97.30M | 103.24M | 46.47M | 42.04M |
| Inventory | 26.51M | 18.58M | 12.18M | 11.04M | 6.99M |
| Prepaid Expenses | 13.27M | 8.96M | 7.75M | 6.49M | 6.71M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 742.05M | 713.16M | 682.77M | 602.25M | 587.91M |
|
|
|||||
| Total Current Assets | 742.05M | 713.16M | 682.77M | 602.25M | 587.91M |
| Net Property, Plant & Equipment | 161.45M | 163.06M | 165.47M | 166.86M | 168.23M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 231.00K | 203.00K | 126.00K | 196.00K | 263.00K |
| Total Assets | 1.06B | 982.32M | 917.66M | 853.30M | 818.36M |
|
|
|||||
| Total Accounts Payable | 4.99M | 5.58M | 5.43M | 5.36M | 4.13M |
| Total Accrued Expenses | 52.78M | 43.36M | 31.71M | 18.26M | 18.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.22M | 1.29M | 1.36M | 1.43M | 1.47M |
| Total Finance Division Other Current Liabilities | 43.02M | 39.30M | 33.36M | 22.54M | 9.34M |
| Total Other Current Liabilities | 43.02M | 39.30M | 33.36M | 22.54M | 9.34M |
| Total Current Liabilities | 102.00M | 89.53M | 71.85M | 47.59M | 33.09M |
|
|
|||||
| Total Current Liabilities | 102.00M | 89.53M | 71.85M | 47.59M | 33.09M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.04M | 6.18M | 6.33M | 6.47M | 6.62M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.42M | 761.00K | 588.00K | -- | -- |
| Total Liabilities | 109.46M | 96.47M | 78.77M | 54.05M | 39.71M |
|
|
|||||
| Common Stock & APIC | 1.13B | 1.11B | 1.09B | 1.07B | 1.05B |
| Retained Earnings | -180.67M | -226.15M | -253.33M | -268.90M | -269.83M |
| Treasury Stock & Other | -190.00K | 1.51M | -634.00K | -299.00K | 638.00K |
| Total Common Equity | 946.38M | 885.85M | 838.89M | 799.24M | 778.64M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 946.38M | 885.85M | 838.89M | 799.24M | 778.64M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 946.38M | 885.85M | 838.89M | 799.24M | 778.64M |
|
|
|||||
